Verónica Sanguine

Verónica Sanguine

Auto-generated profile, based on publicly available information

Verónica Sanguine

Dirección Nacional de Calidad en Servicios de Salud y Regulación Sanitaria, Ministerio de Salud de la Nación, Buenos Aires, Argentina. ORCID:

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
AIAriel Izcovich
Ariel Izcovich
MRMartín Ragusa
Martín Ragusa
VSVerónica Sanguine
Verónica Sanguine
FTFernando Tortosa
Fernando Tortosa
FEFederico Espinosa
Federico Espinosa
CGCOVID-19 L·OVE Working Group
COVID-19 L·OVE Working Group
Objective The objective of our systematic review is to identify prognostic factors that can potentially be used in decision-making related to the care of patients infected with COVID-19. Design This is the protocol of a living systematic review. Data sources We will conduct searches in PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), grey literature and in a centralised repository in L·OVE (Living OVerview of Evidence). L·OVE is a platform that maps PICO questions to evidence from Epistemonikos database. In response to the COVID-19 emergency, L·OVE was adapted to expand the range of evidence covered and customised to group all COVID-19 evidence in one place. The search will continue until the day before submission to a journal. Eligibility criteria for selecting studies and methods We will follow a common protocol for multiple parallel systematic reviews, already published and submitted to PROSPERO (awaiting ID allocation). We will include studies that assess patients with confirmed or suspected SARS-CoV-2 infection and inform the relation between potential prognostic factors and death or disease severity. Two groups of two reviewers will independently screen studies for eligibility, extract data and assess the risk of bias. We will perform meta-analyses and use GRADE to assess the certainty of evidence for each prognostic factor and outcome. A living, web-based version of this review will be openly available during the COVID-19 pandemic. We will resubmit it if the conclusions change or there are substantial updates. Ethics and dissemination No ethics approval is considered necessary. The results of this review will be widely disseminated via peer-reviewed publications, social networks and traditional media. PROSPERO Registration Submitted to PROSPERO (awaiting ID allocation).

27 May 2021 in Medwave
Verified
Journal Article
Open access
FTFernando Tortosa
Fernando Tortosa
AIAriel Izcovich
Ariel Izcovich
GCGabriela Carrasco
Gabriela Carrasco
GVGabriela Varone
Gabriela Varone
PHPedro Haluska
Pedro Haluska
VSVerónica Sanguine
Verónica Sanguine
Introduction Oxygen therapy through a high-flow nasal cannula is thought to improve the work of breathing and the comfort of patients with acute bronchiolitis. It is widely used in hospital wards and critical care of pediatric patients. However, there is uncertainty on the magnitude of the effect on critical and important outcomes in these patients. Objectives The objective of this review is to evaluate the available evidence on the use of oxygen administered through high-flow cannula versus low-flow oxygen for the treatment of acute bronchiolitis in children under two years of age. Methodology We carried out a systematic review and a meta-analysis following the PRISMA standards for reporting. The search was carried out in electronic databases by two researchers independently. The evidence was summarized using the GRADE methodology. Results Six randomized and non-randomized clinical trials were included, including 1867 individuals younger than 24 months of age with acute bronchiolitis in pediatric emergency, hospitalization, and intensive care services. Mortality was not reported in the included studies. Treatment failure occurred in 108/933 in the high flow group and 233/934 in the low flow group (relative risk: 0.46; 95% confidence interval: 0.35 to 0.62), which shows 11.7% less treatment failure (95% confidence interval between 7.9% and 14.5% less) in the high flow group with a number needed to treat of 7.5 (95% confidence interval 6 to 10) with moderate certainty in the evidence. Conclusion The use of humidified and heated oxygen with high flow compared to oxygen at low flow is probably associated with decreased treatment failure in children younger than two years with acute bronchiolitis. There is uncertainty about the effect on hospitalization days and clinical progression.

15 September 2020 in Evidencia - actualizacion en la práctica ambulatoria
Verified
Journal Article
Closed access
PDF file
FTFernando Tortosa
Fernando Tortosa
GBGiselle Balaciano
Giselle Balaciano
GCGabriela Carrasco
Gabriela Carrasco
SCSilvia Clelia Chaves
Silvia Clelia Chaves
GMGuadalupe Montero
Guadalupe Montero
VSVeronica Laura Sanguine
Veronica Laura Sanguine
En epidemias de enfermedades altamente infecciosas como el COVID-19, de transmisión a través de gotas expulsadas por la boca de la persona infectada, los trabajadores de la salud tienen un riesgo mayor de infección que la población en general, debido a su contacto con fluidos corporales y aerosoles generados por los pacientes. La existencia de un porcentaje que podría llegar a ser de hasta un 50%, de portadores asintomáticos con capacidad de contagio, preocupa al momento de planificar la atención quirúrgica. Con el objetivo de desarrollar la presente guía, se realizó una síntesis y valoración crítica de la evidencia disponible sobre el tema, con el fin de responder determinadas preguntas clínicas (utilización de barbijo N95 vs barbijo quirúrgico en cirugía, realización de test diagnóstico para SARS-CoV2 previo a cirugía) utilizando metodología GRADE. La mascarilla N95 podría ser beneficiosa en el personal que realiza procedimientos que favorecen la aerosolización del virus, tales como traqueostomía y ventilación manual con bolsa de autoinsuflación previo a la intubación, entre otros. El testeo del paciente, previo a una cirugía, puede ser considerado en escenarios en los que existe disponibilidad de la determinación. Es necesario evaluar la complejidad de la cirugía, evitando que el retraso causado por la realización de la prueba resulte en daño para el paciente. El conjunto de recomendaciones debe ser implementado teniendo en cuenta el recurso disponible de equipos de protección personal, las características de las intervenciones quirúrgicas (procedimientos que generen aerosoles) y el tipo de circulación viral en la población general (existencia de transmisión comunitaria).